Appendix, on disclosure rules, to the functional specifications for the EU portal and EU database to be audited
Appendix, on disclosure rules, to the functional specifications for the EU portal and EU database to be audited
Appendix, on disclosure rules, to the functional specifications for the EU portal and EU database to be audited
Questions and answers on public consultation on implementation of transparency requirements of the European Clinical Trial Regulation
Draft proposal for an addendum, on transparency, to the 'functional specifications for the European Union (EU) portal and EU database to be audited'
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 10, Status: Authorised
Sixth Nitrosamine Implementation Oversight Group (NIOG) - meeting with pharmaceutical industry, from 07/12/2023 to 07/12/2023
Sixth Nitrosamine Implementation Oversight Group (NIOG) , from 07/12/2023 to 07/12/2023
Twelfth Nitrosamine Implementation Oversight Group (NIOG) meeting, from 06/12/2023 to 06/12/2023
Opinion/decision on a Paediatric investigation plan (PIP): Lanthanum carbonate hydrate, decision type: , therapeutic area: , PIP number: P/0507/2022
Human medicines European public assessment report (EPAR): Defitelio, defibrotide, Hepatic Veno-Occlusive Disease, Date of authorisation: 18/10/2013, Revision: 15, Status: Authorised
Gemcitabine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001519/202301